Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer?. (January 2022)

• Record Type: Journal Article
• Authors: Cui, Binxin; Lin, Lin; Wang, Bangmao; Liu, Wentian; Sun, Chao
• Is Part Of: Pharmacological research. Volume 175(2022)
• Publication Date: 2022-01
• Subjects: Saccharomyces boulardii S. boulardii -- NASH nonalcoholic steatohepatitis -- NAFLD nonalcoholic fatty liver disease -- LPS lipopolysaccharide -- PAMPs pathogen-associated molecular patterns -- SCFA short-chain fatty acids -- GSH glutathione -- ALI acute liver injury -- ALF acute liver failure -- CLA clarithromycin -- MTX methotrexate -- MDA malondialdehyde -- D-GalN D-Galactosamine -- FMT fecal microbiota transplantation -- ECM extracellular matrix -- HSCs hepatic stellate cells -- α-SMA α-smooth muscle actin -- CCl4 carbon tetrachloride -- ROS excessive reactive oxygen species -- RCD regulated cell death; Saccharomyces boulardii -- Saccharomyces cerevisiae -- Liver disease -- Probiotics -- Liver injury -- Antioxidant; Pharmacology -- Periodicals; Pharmacology -- Periodicals; Research -- Periodicals; Médicaments -- Recherche -- Périodiques; Pharmacologie -- Périodiques; 615.105
• DOI: 10.1016/j.phrs.2021.106022
• Languages: English
• ISSNs: 1043-6618

Abstract

Abstract: Saccharomyces boulardii ( S. boulardii ) is a probiotic yeast that has been elucidated to be efficacious in fighting various gastrointestinal diseases in preclinical as well as clinical studies. Its general mechanisms of probiotic action in the treatment of gastrointestinal conditions cover multifaceted aspects, including immune regulation, production of antimicrobial substances, pathogen competitive elimination, gut barrier integrity maintenance, intestinal trophic effect and antioxidant potency. In this review, basic knowledge with regard to the gut-liver axis, available probiotics remedies and mechanistic insights of S. boulardii as probiotics will be elucidated. In addition, we summarize the therapeutic potential of S. boulardii in several liver diseases evident from both bench and bedside information, such as acute liver injury/failure, fibrosis, hepatic damages due to metabolic disturbance or infection and obstructive jaundice. Future prospects in relation to medicinal effects of S. boulardii are also exploited and discussed on the basis of novel and attractive therapeutic concept in the latest scientific literature. Graphical Abstract: ga1 Highlights: Saccharomyces boulardii is a probiotic yeast to be efficious in various liver diseases in preclinical and clinical studies. The probiotic action of Saccharomyces boulardii appears to be multifaceted. Further evidence has provided attractive therapeutic concept linking this yeast to genetically engineering, regulated cell death and genetic signature.